Logo Logo
Help
Contact
Switch Language to German
Treitl, Karla M.; Ali, Alma; Treitl, Marcus (2016): Safety and efficiency of femoral artery access closure with a novel biodegradable closure device: a prospective single-centre pilot study. In: European Radiology, Vol. 26, No. 7: pp. 2359-2368
Full text not available from 'Open Access LMU'.

Abstract

Objectives Vascular closure devices can accelerate haemostasis after arteriotomy, but induce scarring. The aim of the study was to prospectively analyse the feasibility of a novel biodegradable arterial closure device (CD). Two hundred fifty-five patients (183 male;age 36-98 years) with an access vessel diameter > 3 mm received the biodegradable CD after endovascular therapy. Technical success rate, time-to-haemostasis (TTH) and time-to-ambulation (TTA) were measured. Puncture site complications were categorized as minor (local hematoma, minor bleeding) or major (pseudoaneurysm, embolization, dissection, thrombotic occlusion, hematoma/major bleeding requiring surgery, access site infection). Technical success was achieved in 98.8 % (252 cases);device failure occurred in three cases (1.2 %). The average TTH and TTA were 11.3 +/- 26.9 s and 73.0 +/- 126.3 min. The major complication rate was 1.6 %, with three pseudoaneurysms and one retroperitoneal bleeding. The minor complication rate was 2.0 %, with five small hematomas. Neither cardiovascular risk factors nor access vessel characteristics had statistically significant influence on adverse events. Re-puncture was uncomplicated in 32 cases after 155.0 +/- 128.8 days. Handling of the new biodegradable CD is safe. The complication rates are tolerably low and comparable to other CDs. Post-procedural sonography showed no significant palpable subcutaneous changes in the access site. aEuro cent VCDs can increase time efficiency and patient comfort after intervention. aEuro cent In this prospective single-centre-study, biodegradable CD was safe and easily applicable. aEuro cent Its major and minor complication rates are comparable to other CDs. aEuro cent Its mean time-to-haemostasis and time-to-ambulation were 11.3 +/- 26.9 s and 73.0 +/- 126.3 min. aEuro cent Post-procedural sonography showed no significant palpable subcutaneous changes at the access site.